Abstract
Oestrogen receptor (ER) is used routinely to predict endocrine responsiveness in patients with breast cancer. A second ER, ERβ has been described but its significance remains undefined; most studies have described mRNA levels rather than protein expression. Here, we demonstrate for the first time, immunohistochemical detection of ERβ in archival breast tumours.
| Original language | English |
|---|---|
| Pages (from-to) | 1095-1098 |
| Number of pages | 4 |
| Journal | British Journal of Cancer |
| Volume | 84 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 20 Apr 2001 |
| Externally published | Yes |
Funding
We thank Yorkshire Cancer Research and Northern and Yorkshire NHS Executive for financial support. Thanks to Jane Ramsdale for technical assistance.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Breast cancer
- ERβ
- Formalin-fixed
- Immunohistochemistry
- Paraffin-embedded material
Fingerprint
Dive into the research topics of 'Immunohistochemical detection of ERβ in breast cancer: Towards more detailed receptor profiling?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS